The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish ...

The GLP-1 agonists won’t be cheap any time soon as generic versions remain far in the future: The US patents for Ozempic and Wegovy won’t expire for another six or seven years. It is true that ...

There's an emerging market of "natural" supplements that claim to cause weight loss like Ozempic and similar drugs. Hunterframe - stock.adobe.com UK scientists said they have developed a low-cost ...

The Jon & Kate Plus 8 alum told Page Six in April 2024 that he lost 32 pounds in two months after taking injections of semaglutide, the generic form of Ozempic. "You know what's annoying?" ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Neither drug is considered as effective as the brand-name weekly injections sold for diabetes and weight loss as Ozempic and Wegovy ... "prioritizes assessment of generic drug applications for ...

Those include Ozempic and its sister drug approved ... just without the brand name on the label. A generic drug, like the liraglutide generic approved Monday, is a copy of a brand-name drug ...